Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Altimmune's pemvidutide shows strong Phase IIb results for MASH, promising Phase III prospects. Read here for more analysis ...

Novo Nordisk NVO announced the FDA approval of Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight ...

SD: There’s a lot of hesitation up front. Putting in an alignment system takes up some precious square footage. What they end ...

Amgen Inc. (NASDAQ:AMGN) is a global biotechnology company recognised for its focus on biologic medicines addressing serious ...

The results indicate that pemvidutide achieved significant reductions in primary non-invasive markers of fibrosis.

GEN lists the top five performing biotech stocks of 2025 and the five biotech stocks that fell the most during this past year, with brief explanations for the increases or declines.

On top of the grind at Superior Beverage, Corto is also the founder of the Spiders Lacrosse Club in Chagrin Falls. He started playing in high school in Baltimore, continued into college — he was a ...

End-of-Phase 2 interactions with FDA complete; scientific advice received from EMA – – Company expects to dose first patient in global Phase 3 registrational trial, MAPKeeper 301, in mid-2026 – – ...

Company to present 40-week topline results from the Phase 2 study of migaldendranib (MGB), a first-in-class subcutaneous nanomedicine, being developed for the treatment of DME and nAMD FDA alignment ...